AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimisave M CP 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimisave M CP 2mg/500mg Tablet

Combiflex DM 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients for adult type 2 diabetes management. This treatment helps regulate blood glucose levels. Combiflex DM should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical counsel, risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests for blood cell counts and liver function are recommended.

Primary Ingredients of Glimisave M CP 2mg/500mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Glimisave M CP 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimisave M CP 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimisave M CP 2mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Glimisave M CP 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisave M CP 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimisave M CP 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Glimisave M CP 2mg/500mg Tablet works:

Glimisave M CP, a 2mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisave M CP 2mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimisave M CP 2mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimisave M CP 2mg/500mg tablets while breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimisave M CP 2mg/500mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients with severe kidney disease should not receive this medication. Close monitoring of renal function is recommended during treatment. Consult a physician before administering.

LiverLiverCAUTION

For individuals with liver impairment, the use of Glimisave M CP 2mg/500mg tablets requires careful monitoring. Dosage modification of Glimisave M CP 2mg/500mg tablets may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver disease, Glimisave M CP 2mg/500mg tablets are typically initiated at a low dosage; however, their use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimisave M CP 2mg/500mg Tablet :

Should you forget to take a Glimisave M CP 2mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimisave M CP 2mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Medication

FAQs on Glimisave M CP 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimisave M CP 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Glimisave M CP 2mg/500mg Tablets, if you experience these symptoms.
Glimisave M CP 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimisave M CP 2mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimisave M CP 2mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimisave M CP 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimisave M CP 2mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimisave M CP 2mg/500mg ...
156
MRP 180
13% off